Bone marrow-derived mesenchymal stem cells suppress NK cell recruitment and activation in PolyI:C-induced liver injury

Biochemical and Biophysical Research Communications

Volumn 466, Issue 2, 2015, Pages 173-179

  Qu, Mengmeng ^a   Cui, Jun ^a   Zhu, Jun ^a   Ma, Yuhong ^a   Yuan, Xu ^a   Shi, Jinming ^a   Guo, Deyin ^a   Li, Changyong ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Liver injury; MSCs; NK cells; S1PR5

Indexed keywords

ALANINE AMINOTRANSFERASE; POLYINOSINIC POLYCYTIDYLIC ACID; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 5; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL ACTIVATION; CELL FUNCTION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; LIVER INJURY; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; LIVER; MESENCHYMAL STROMA CELL;

ANIMALS; CELLS, CULTURED; KILLER CELLS, NATURAL; LIVER; MESENCHYMAL STROMAL CELLS; MICE; POLY I-C;

EID: 84942294446     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.08.125     Document Type: Article

References (33)

1. A. Uccelli, V. Pistoia, and L. Moretta Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol. 28 2007 219 226
2. F. Dazzi, L. Lopes, and L. Weng Mesenchymal stromal cells: a key player in innate tolerance'? Immunology 137 2012 206 213
3. A. Gebler, O. Zabel, and B. Seliger The immunomodulatory capacity of mesenchymal stem cells Trends Mol. Med. 18 2012 128 134
4. Y.F. Shi, G.Z. Hu, J.J. Su, W.Z. Li, Q. Chen, P.S. Shou, C.L. Xu, X.D. Chen, Y. Huang, Z.X. Zhu, X. Huang, X.Y. Han, N.X. Xie, and G.W. Ren Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair Cell Res. 20 2010 510 518
5. Y.N. Kallis, M.R. Alison, and S.J. Forbes Bone marrow stem cells and liver disease Gut 56 2007 716 724
6. V. Racanelli, and B. Rehermann The liver as an immunological organ Hepatology 43 2006 S54 S62
7. B. Gao, W.I. Jeong, and Z.G. Tian Liver: an organ with predominant innate immunity Hepatology 47 2008 729 736
8. G. Tiegs, J. Hentschel, and A. Wendel A T-cell-dependent experimental liver-injury in mice inducible by concanavalin-A J. Clin. Invest 90 1992 196 203
9. E. Jirillo, D. Caccavo, T. Magrone, E. Piccigallo, L. Amati, A. Lembo, C. Kalis, and M. Gumenscheimer The role of the liver in the response to LPS: experimental and clinical findings J. Endotoxin Res. 8 2002 319 327
10. Z.J. Dong, H.M. Wei, R. Sun, Z.Q. Hu, B. Gao, and Z.G. Tian Involvement of natural killer cells in PolyI: C-induced liver injury J. Hepatol. 41 2004 966 973
11. T. Walzer, L. Chiossone, J. Chaix, A. Calver, C. Carozzo, L. Garrigue-Antar, Y. Jacques, M. Baratin, E. Tomasello, and E. Vivier Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor Nat. Immunol. 8 2007 1337 1344
12. K. Mayol, V. Biajoux, J. Marvel, K. Balabanian, and T. Walzer Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking Blood 118 2011 4863 4871
13. C.N. Jenne, A. Enders, R. Rivera, S.R. Watson, A.J. Bankovich, J.P. Pereira, Y. Xu, C.M. Roots, J.N. Beilke, A. Banerjee, S.L. Reiner, S.A. Miller, A.S. Weinmann, C.C. Goodnow, L.L. Lanier, J.G. Cyster, and J. Chun T-bet-dependent S1P(5) expression in NK cells promotes egress from lymph nodes and bone marrow J. Exp. Med. 206 2009 2469 2481
14. T.P. Salazar-Mather, J.S. Orange, and C.A. Biron Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1 alpha (MIP-1 alpha)-dependent pathways J. Exp. Med. 187 1998 1 14
15. T.P. Salazar-Mather, C.A. Lewis, and C.A. Biron Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1 alpha delivery to the liver J. Clin. Invest 110 2002 321 330
16. Z.G. Tian, Y.Y. Chen, and B. Gao Natural killer cells in liver disease Hepatology 57 2013 1654 1662
17. K. Hudspeth, E. Pontarini, P. Tentorio, M. Cimino, M. Donadon, G. Torzilli, E. Lugli, S. Della Bella, M.E. Gershwin, and D. Mavilio The role of natural killer cells in autoimmune liver disease: a comprehensive review J. Autoimmun. 46 2013 55 65
18. I. Sakaida, S. Terai, N. Yamamoto, K. Aoyama, T. Ishikawa, H. Nishina, and K. Okita Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice Hepatology 40 2004 1304 1311
19. S. Terai, T. Ishikawa, K. Omori, K. Aoyama, Y. Marumoto, Y. Urata, Y. Yokoyama, K. Uchida, T. Yamasaki, Y. Fujii, K. Okita, and I. Sakaida Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy Stem Cells 24 2006 2292 2298
20. F.P. Russo, M.R. Alison, B.W. Bigger, E. Amofah, A. Florou, F. Amin, G. Bou-Gharios, R. Jeffery, J.P. Iredale, and S.J. Forbes The bone marrow functionally contributes to liver fibrosis Gastroenterology 130 2006 1807 1821
21. T. Kisseleva, H. Uchinami, N. Feirt, O. Quintana-Bustamante, J.C. Segovia, R.F. Schwabe, and D.A. Brenner Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis J. Hepatol. 45 2006 429 438
22. L.V. Di Bonzo, I. Ferrero, C. Cravanzola, K. Mareschi, D. Rustichell, E. Novo, F. Sanavio, S. Cannito, E. Zamara, M. Bertero, A. Davit, S. Francica, F. Novelli, S. Colombatto, F. Fagioli, and M. Parola Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential Gut 57 2008 223 231
23. C.Y. Li, Y.X. Kong, H. Wang, S.L. Wang, H. Yu, X. Liu, L. Yang, X.M. Jiang, L.S. Li, and L.Y. Li Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis J. Hepatol. 50 2009 1174 1183
24. M. Di Nicola, C. Carlo-Stella, M. Magni, M. Milanesi, P.D. Longoni, P. Matteucci, S. Grisanti, and A.M. Gianni Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 99 2002 3838 3843
25. M.M. Rosado, M.E. Bernardo, M. Scarsella, A. Conforti, E. Giorda, S. Biagini, S. Cascioli, F. Rossi, I. Guzzo, M. Vivarelli, L. Dello Strologo, F. Emma, F. Locatelli, and R. Carsetti Inhibition of B-Cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells Stem Cells Dev. 24 2015 93 103
26. G.M. Spaggiari, A. Capobianco, S. Becchetti, M.C. Mingari, and L. Moretta Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation Blood 107 2006 1484 1490
27. G.M. Spaggiari, A. Capobianco, H. Abdelrazik, F. Becchetti, M.C. Mingari, and L. Moretta Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2 Blood 111 2008 1327 1333
28. P.A. Sotiropoulou, S.A. Perez, A.D. Gritzapis, C.N. Baxevanis, and M. Papamichail Interactions between human mesenchymal stem cells and natural killer cells Stem Cells 24 2006 74 85
29. K. Nemeth, A. Leelahavanichkul, P.S.T. Yuen, B. Mayer, A. Parmelee, K. Doi, P.G. Robey, K. Leelahavanichkul, B.H. Koller, J.M. Brown, X.Z. Hu, I. Jelinek, R.A. Star, and E. Mezey Bone marrow stromal cells attenuate sepsis via prostaglandin E-2-dependent reprogramming of host macrophages to increase their interleukin-10 production Nat. Med. 15 2009 42 49
30. M.H. Abumaree, M.A. Al Jumah, B. Kalionis, D. Jawdat, A. Al Khaldi, F.M. Abomaray, A.S. Fatani, L.W. Chamley, and B.A. Knawy Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from Inflammatory M1 to anti-inflammatory M2 macrophages Stem Cell Rev. 9 2013 620 641
31. X.X. Jiang, Y. Zhang, B. Liu, S.X. Zhang, Y. Wu, X.D. Yu, and N. Mao Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells Blood 105 2005 4120 4126
32. F. Djouad, L.M. Charbonnier, C. Bouffi, P. Louis-Plence, C. Bony, F. Apparailly, C. Cantos, C. Jorgensen, and D. Noel Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism Stem Cells 25 2007 2025 2032
33. Y. Lu, J. Liu, Y. Liu, Y. Qin, Q. Luo, Q. Wang, and H. Duan TLR4 plays a crucial role in MSC-induced inhibition of NK cell function Biochem. Biophys. Res. Commun. 464 2015 541 547